Venmax Drugs And Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/01/2025 ,inter alia, to consider and approve Intimation of Board Meeting pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding increase in the Authorised Capital and Issue of share warrants and Issue of Equity shares on preferential basis.
Board Meeting Intimation for Increase In Authorised Capital And Fund Raising Proposal.
Filed with BSE · · 2 pages · English
On 6ix: 6ix.com/news/board-meeting-intimation-for-increase-in-authorised-capital-and-fund-raising-proposal
Release
Venmax Drugs & Pharmaceuticals Ltd. on 6ix
Earlier from Venmax Drugs & Pharmaceuticals
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 31 2024
- Closure of Trading Window
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 27 2024
- Announcement under Regulation 30 (LODR)-Cessation
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2024
Later from Venmax Drugs & Pharmaceuticals
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 10 2025
- Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 13 2025
- We Would Like To Inform You That The Extra-Ordinary General Meeting Is Schedule To Be Held On Thursday, February 06, 2025, At 12: 00 PM Through Video Conferencing Or Other Audio Visual Means ("OAVM").
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.
Follow Venmax Drugs & Pharmaceuticals